We are happy to join our partners at the European Patients’ Forum (EPF) in announcing that on Monday 25 of October health Commissioner Stella Kyriakides announced on Twitter that “Civil society make an i […]

As 2021 draws to a close, DiCE will use its policy and political outreach activities carried out during the year as a strong basis for its work in 2022.

Key policy points that DiCE has been monitoring and adding […]

Last month we launched our biosimilars education microsite, which forms part of the DiCE website. The microsite includes a plethora of information for patients and healthcare practitioners on this important topic, […]

Our 2021 Masterclass has come to an end. Thank you to all those who attended and spoke – we would have so liked to have met live and have been together in Barcelona in June. But as we all know this option was […]

Our Member organisation ACCGG from Spain – the only organisation in Spain dedicated to supporting patients with gastric cancer and people with gastrectomies exclusively – organised many activities throughout […]

This year, we received three excellent proposals from our Member Organisations on work around colorectal cancer as a response to our annual call for the Wolfram Nolte Memorial Award. Thank you to the three […]

On October 21 the European Commission (EC) approved the use of nivolumab (Opdivo®) plus chemotherapy for the first line treatment of adult patients with HER2-negative advanced or metastatic gastric, […]

2021 marks the 15-year anniversary of the first biosimilar medicine being approved in Europe. To honour this anniversary and acknowledge the important role of biosimilars within cancer treatment in transforming […]

November 18 is World Pancreatic Cancer Day. In 2020, 140.116 new cases of pancreatic cancer were reported and it is the fourth cause of death by cancer in Europe1. Please join us on November 4 for our Masterclass […]

It has been officially announced that in 2022, the European Commission (EC) will make a proposal to update the 2003 Council Recommendation on cancer screening to ensure that the EU guidelines are up to date with […]

We are at a crossroads in our fight against liver cancer in Europe, as stated in the DiCE and ELPA joint White Paper, Liver Cancer: No Patient Left Behind. Unfortunately, it is a fight we are currently losing. […]

DiCE laid out a Call for Action for “Improving the Use of Biosimilar Medicines in Colorectal Cancer through the Adaptation of EU Policies” at the end of September. This was at its policy event “The Value Biosi […]

Digestive Cancers Europe’s French Member ‘Mon Réseau Cancer Colorectal’ (MRCC) had the honour of bringing together 16 French speaking patient associations from three continents to discuss at a half-day sessio […]

Digestive Cancers Europe CEO, Zorana Maravic, participated at the Cancer Screening Expert Workshop organized by the Federation of European Academies of Medicine (FEAM). Here she represented the patient voice in […]

November is another important month for the digestive cancers community as it is dedicated to raising awareness around gastric cancer. Each year ~136.000 people are diagnosed with gastric cancer, while ~97.000 […]

The involvement of cancer patients’ and carers’ voices in health and social care research is gradually but steadily evolving. Last month we were pleased to feature this article covering the EU Trio Council Pre […]

At the end of last summer – August 2020 – the project ‘EU-TOPIA: Towards Improved Screening for Breast, Cervical and Colorectal Cancer in all of Europe’, came to its conclusion. The European Commission funded […]